DRUG
Bright Minds Biosciences
DRUG
DRUG
63 hedge funds and large institutions have $366M invested in Bright Minds Biosciences in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
34% more funds holding
Funds holding: 47 → 63 (+16)
11.32% more ownership
Funds ownership: 74.34% → 85.66% (+11%)
Holders
63
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$11.8M | |
| 2 | +$9.71M | |
| 3 | +$7.6M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.26M |
| 5 |
SCM
Superstring Capital Management
New York
|
+$2.09M |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$1.94M | |
| 3 | -$1.35M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.16M |
| 5 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
-$365K |
